We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-3 of 3

industry news
  • Borden Ladner Gervais LLP
  • Canada, Global
  • April 6 2011

The Management of Drug Submissions Guidance has been revised to include changes resulting from the release of the new Fees in Respect of Drugs and Medical Devices Regulations

Beverley Moore
  • Borden Ladner Gervais LLP